Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

FDA panel backs Takeda’s inflammatory bowel disease drug

Vedolizumab on course for US approval to treat Crohn’s disease and ulcerative colitis

- PMLiVE

This month in 1901: The first Nobel Prize awards

Serum therapy work took inaugural medicine award

- PMLiVE

Sanofi’s Aubagio backed by NICE

Oral MS drug recommended for NHS use in England and Wales

- PMLiVE

Novartis’ Tasigna tops Glivec in long-term trial

Boost ahead of patent expiry for leukaemia drug

- PMLiVE

AZ donates Brixham lab to Plymouth University

Will create global research and education facility

- PMLiVE

Senior hires at Precision Health Media

New VP for ad sales, chief financial officer ad member of the board

- PMLiVE

Ketchum loses healthcare head

Amanda Sefton leaves to pursue “passion project” in wine trade

FDA reins in Google-backed genetics company 23andMe

Health-related genetic test service put on hold pending US regulatory review

- PMLiVE

MSD appoints new UK head

Mike Nally moves from Swedish division

- PMLiVE

Study highlights poor diabetes consultation

Less than a third of patients asked for input into their treatment plans

- PMLiVE

AZ wins EU approval for four-strain flu vaccine

Fluenz Tetra offers competition to GSK’s Influsplit Tetra/Fluarix Tetra

- PMLiVE

Auxilium’s Xiaflex cleared in US for erection disorder

FDA approval to treat Peyronie's disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links